Ropes & Gray advised Genzyme Corporation in the sale of its Genzyme Genetics business unit to Laboratory Corporation of America Holdings (LabCorp) for $925 million in cash, announced September 13. Under the terms of the agreement, LabCorp will purchase the business in its entirety, including all testing services, technology, intellectual property rights, and its nine testing laboratories.
The Ropes & Gray team was led by Christopher Comeau.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.